BONNER EIMEAR P 4
4 · CHEVRON CORP · Filed Mar 3, 2026
Research Summary
AI-generated summary of this filing
Chevron (CVX) CFO Eimear Bonner Exercises Options, Sells Shares
What Happened
- Eimear P. Bonner, Chevron’s Chief Financial Officer, exercised options and then sold the resulting shares. On Feb 27 and Mar 2, 2026 she exercised a total of 45,800 shares (18,800 @ $152.35; 9,600 @ $153.22; 17,400 @ $179.08) at a total exercise cost of $7,451,084. She sold 45,800 shares in multiple open‑market transactions that produced total proceeds of $8,600,515 (sales executed at weighted‑average prices ranging roughly from $184 to $191).
Key Details
- Transaction dates: Feb 27, 2026 and Mar 2, 2026.
- Exercises (M): 18,800 @ $152.35 ($2,864,180); 9,600 @ $153.22 ($1,470,912); 17,400 @ $179.08 ($3,115,992). Total exercise cost ≈ $7.45M.
- Sales (S): 5,500 @ $184.28; 2,500 @ $185.33; 18,100 @ $186.56; 2,300 @ $187.16; 17,400 @ $190.60. Total proceeds ≈ $8.60M. Several sales reported as weighted averages with per‑trade price ranges (see footnotes).
- Shares owned after the transactions: not specified in the provided filing details.
- Notable footnotes: sales were made pursuant to a Rule 10b5‑1 trading plan adopted Nov 22, 2025 (F1). Multiple sale price ranges and weighted‑average prices are reported (F3–F6). Option grant and vesting details are included (grants dated 1/25/2023, 2/6/2024, 2/4/2025 with staged vesting — F7–F9).
- Timeliness: Form 4 was filed on Mar 3, 2026 for transactions on Feb 27 and Mar 2, 2026; the filing appears to be timely under the SEC two‑business‑day rule.
Context
- These were option exercises (derivative code M) followed by immediate open‑market sales. The filing shows the exercise (acquisition) lines and separate sale lines; some derivative reporting lines list $0.00 as the disposition amount — that reflects the reporting format for option conversion rather than a cash sale. The reported sales were executed under a prearranged 10b5‑1 plan, which typically indicates scheduled transactions rather than ad‑hoc trades.
- Facts only — this record shows both an exercise (acquiring shares via option exercise) and substantial sales of those shares; it does not, by itself, indicate management’s view of Chevron’s near‑term prospects.
Insider Transaction Report
Form 4
CHEVRON CORPCVX
BONNER EIMEAR P
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
[F1][F2]2026-02-27$152.35/sh+18,800$2,864,180→ 27,228 total - Exercise/Conversion
Common Stock
[F1]2026-02-27$153.22/sh+9,600$1,470,912→ 36,828 total - Sale
Common Stock
[F1][F3]2026-02-27$184.28/sh−5,500$1,013,527→ 31,328 total - Sale
Common Stock
[F1][F4]2026-02-27$185.33/sh−2,500$463,334→ 28,828 total - Sale
Common Stock
[F1][F5]2026-02-27$186.56/sh−18,100$3,376,745→ 10,728 total - Sale
Common Stock
[F1][F6]2026-02-27$187.16/sh−2,300$430,469→ 8,428 total - Exercise/Conversion
Common Stock
[F1]2026-03-02$179.08/sh+17,400$3,115,992→ 25,828 total - Sale
Common Stock
[F1]2026-03-02$190.60/sh−17,400$3,316,440→ 8,427 total - Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
[F7]2026-02-27−18,800→ 9,400 totalExercise: $152.35Exp: 2034-02-06→ Common Stock (18,800 underlying) - Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
[F8]2026-02-27−9,600→ 19,200 totalExercise: $153.22Exp: 2035-02-04→ Common Stock (9,600 underlying) - Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
[F9]2026-03-02−17,400→ 0 totalExercise: $179.08Exp: 2033-01-25→ Common Stock (17,400 underlying)
Holdings
- 408(indirect: Share Incentive Plan)
Common Stock
Footnotes (9)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2025.
- [F2]This number includes rounding of fractional shares.
- [F3]This transaction was executed in multiple trades at prices ranging from $183.85 to $184.82, inclusive. The price reported in Column 4 reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (6) to this Form.
- [F4]These shares were sold in multiple transactions at prices ranging from $184.85 to $185.83, inclusive. The price reported in Column 4 reflects the weighted average sale price.
- [F5]These shares were sold in multiple transactions at prices ranging from $185.87 to $186.85, inclusive. The price reported in Column 4 reflects the weighted average sale price.
- [F6]These shares were sold in multiple transactions at prices ranging from $186.95 to $187.43, inclusive. The price reported in Column 4 reflects the weighted average sale price.
- [F7]Option granted 2/6/2024. One-third of the shares subject to the option vested on February 10, 2025 and February 10, 2026, respectively, and one-third of the shares will vest on February 10, 2027.
- [F8]Option granted 2/4/2025. One-third of the shares subject to the option vested on February 10, 2026 and one-third of the shares will vest on February 10, 2027 and February 10, 2028, respectively.
- [F9]Option granted 1/25/2023. One-third of the shares subject to the option vested on January 31, 2024, January 31, 2025 and January 31, 2026, respectively.
Signature
/s/ Rose Z. Pierson, Attorney-in-Fact for Eimear P. Bonner|2026-03-03